ROCKLAND, INC.

Basic Information

650 ENGLESVILLE RD
BOYERTOWN, PA, 19512-8407

Company Profile

n/a

Additional Details

Field Value
DUNS: 58999129
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Antibody-based Point-of-Care Device for the Diagnosis of Sickle Cell Disease

    Amount: $449,072.00

    DESCRIPTION provided by applicant Hemoglobinopathies are the most common monogenic diseases with approximately of the worldandapos s population being carriers Sickle cell disease SCD and tha ...

    SBIR Phase I 2014 Department of Health and Human Services National Institutes of Health
  2. TAS::75 0849::TAS SBIR TOPIC 292 PHASE I DEVELOPMENT OF MOLECULAR PHARMACODYNAMIC ASSAYS FOR TARGETED THERAPIES

    Amount: $149,866.00

    The RON and c-MET signal pathways are critical regulators of cell growth, survival, migration, differentiation, and drug resistance. High levels of activated RON or c-MET have been observed in a numbe ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. SBIR TOPIC 229, PHASE II: PHARMACODYNAMIC ASSAY FOR AKT FOR USE WITH PI3K/AKT/MTOR INHIBITORS

    Amount: $999,002.00

    In response to this NCI solicitation, Rockland proposes to develop a novel method to assay the pharmacodynamic (PO) properties of anti-cancer small molecules targeting the PI3K/mTOR/AKT signaling path ...

    SBIR Phase II 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government